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Abstract
Background: To better understand the molecular programs of normal and abnormal genital development, clear-cut definition
of androgen-dependent gene expression patterns, without the influence of genotype (46, XX vs. 46, XY), is warranted.
Previously, we have identified global gene expression profiles in genital-derived fibroblasts that differ between 46, XY males and
46, XY females with complete androgen insensitivity syndrome (CAIS) due to inactivating mutations of the androgen receptor
(AR). While these differences could be due to cell autonomous changes in gene expression induced by androgen programming,
recent work suggests they could also be influenced by the location from which the fibroblasts were harvested (topology). To
minimize the influence of topology, we compared gene expression patterns of fibroblasts derived from identical urogenital
anlagen: the scrotum in normally virilized 46, XY males and the labia majora from completely feminized 46, XY individuals with
CAIS.
Results: 612 transcripts representing 440 unique genes differed significantly in expression levels between scrotum and CAIS
labia majora, suggesting the effects of androgen programming. While some genes coincided with those we had identified
previously (TBX3, IGFBP5, EGFR, CSPG2), a significant number did not, implying that topology had influenced gene expression
in our previous experiments. Supervised clustering of gene expression data derived from a large set of fibroblast cultures from
individuals with partial AIS revealed that the new, topology controlled data set better classified the specimens.
Conclusion: Inactivating mutations of the AR, in themselves, appear to induce lasting changes in gene expression in cultured
fibroblasts, independent of topology and genotype. Genes identified are likely to be relevant candidates to decipher androgen-
dependent normal and abnormal genital development.
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Background
Androgen receptor (AR) signaling is the key determinant
of virilization in male external genitalia development [1-
4]. Its importance is highlighted in the androgen insensi-
tivity syndrome (AIS), a virtual human AR "knock-out"
due to inactivating mutations of the AR gene, and charac-
terized by defects in virilization of 46, XY individuals
despite normal or elevated serum testosterone levels. The
phenotype can range from normal female in complete AIS
(CAIS), to lesser degrees of genital ambiguity in partial AIS
(PAIS) in which the degree of virilization is related to the
degree of AR function [2,3]. Genital masculinization
involves a comprehensive re-organization of genital anat-
omy in which androgens induce a permanent male devel-
opmental fate in the originally bipotent anlagen. For
example, in response to embryonal androgen signaling,
the labioscrotal swellings will develop into a scrotum and
not into labia majora (as overviewed by [5]). These obser-
vations indicate the existence of androgen-mediated gene
expression programs that are responsible for implementa-
tion and persistence of male-specific genital morphology
and function. In general, distinguishing X- and Y-chromo-
somal influences from hormonal influences on genital
development has proven difficult [6,7]; however, CAIS, in
which all individuals possess an XY genotype, represents
the ideal situation for focusing on the role of androgens.
In a previous study, we reported evidence for androgen-
mediated programming of gene expression by comparing
genital skin fibroblasts from normal males to those
derived from CAIS individuals [8]. However, the demon-
stration that cultured fibroblasts show stable transcription
signatures that reflect their site of origin in mature adult
tissues (transcriptional topographic memory) [9] raises
the possibility that fibroblast transcript signatures might
also reflect androgen-independent aspects of their devel-
opmental history. Were that the case, the transcript signa-
tures we had identified might be influenced both by
androgen signaling during genital development and
topology. Even though the normal male and CAIS fibrob-
lasts were both derived from the genital skin, their precise
sites of biopsy differed both topologically and with regard
to embryological origin. The normal male genital fibrob-
lasts were grown from biopsies of the foreskin (derived
from the genital tubercle), while CAIS fibroblasts came
from biopsies of the labia majora (derived from the labi-
oscrotal swellings) [8]. To better define the gene expres-
sion programs dependent only on developmental
androgen actions, we analyzed gene expression profiles of
fibroblasts derived from homologous embryonic struc-
tures: the labioscrotal swellings in 46, XY males (scrotum)
and 46, XY females (labia majora). We validated the bio-
logical relevance of this approach by comparing the abil-
ity of this new gene expression set and the previous set to
classify a large set of individuals representing the whole
clinical spectrum of AIS phenotypes based on gene expres-
sion profiles alone.
Results
Identification of a topology-independent, AR-dependent 
gene expression program
We had previously identified an AR-dependent gene
expression signature by comparing normal male foreskin
fibroblasts to those cultured from diverse sites in the gen-
itals of patients with documented CAIS. Subsequent
reports that cultured fibroblasts retain topographic tran-
scriptional memory (gene expression signatures that
reflect their site of biopsy) led to concerns that the AR-
dependent gene expression signature we identified could
have been affected by topological differences in the
fibroblast samples used. To test for this potential con-
founder, we repeated microarray experiments on seven
independent strains of normal male scrotal fibroblasts
(S1, S4, S5, S8, S9, S11, and S12) and duplicate samples
of four labia majora fibroblasts derived from 46, XY indi-
viduals with CAIS due to proven inactivating mutations of
the AR-gene. Both fibroblasts were derived from identical
anlagen: the labioscrotal swellings. The SAM procedure
revealed 612 transcripts representing 440 unique genes
that differed significantly in expression level between the
groups at a false discovery rate of 0.038 (Figure 1).
The new topology-controlled data set showed some simi-
larities to the AR-dependent gene set we had identified
previously, with 42 unique transcripts found in both gene
sets, including 34 transcripts that were up-regulated in
normal male derived fibroblasts, and 8 up-regulated in
the CAIS female-derived fibroblasts. Genes up-regulated
in normal male fibroblasts in both data sets included
TBX3 (T-box 3), CBX6 (Chromobox homologue 6),
IGFBP5 (Insulin-like growth factor binding protein 5),
and EGFR (epidermal growth factor receptor) while sev-
eral others were no longer identified as significantly differ-
ent between the data sets, such as TBX2 (T-box 2), TBX5
(T-box 5), BMP4 (bone morphogenetic protein 4),
HOXA13 (Homeobox A13), WNT2 (Wingless-type
MMTV integration site family, member 2), and FOXF2
(Forkheadbox F2). The significant change in the gene lists
strongly suggested that topology influenced the gene
expression signatures identified in our original series of
experiments.
Topology independent AR gene expression program 
classifies diverse AIS samples
To evaluate the relevance of the topology-controlled, AR
dependent gene list, we tested its ability to classify 72
microarray experiments performed on fibroblast samples
derived from 51 individuals that included normal males,
normal females, and individuals with PAIS and CAIS (Fig.
2 and table 1). AIS samples were graded according to theBMC Genomics 2007, 8:376 http://www.biomedcentral.com/1471-2164/8/376
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Transcripts with significant differences of expression levels between normal scrotum and CAIS labia majora Figure 1
Transcripts with significant differences of expression levels between normal scrotum and CAIS labia majora. 
Transcript levels of 612 genes identified by SAM analysis as differing between fibroblasts derived from normal male scrotum 
(green) and labia majora of 46, XY females with CAIS (pink). Individual transcripts are grouped by hierarchical cluster analysis 
and are displayed in rows while experiments are represented in columns. Expression values per gene are centered by the mean 
log2 red/green normalized ratio. Increasing red intensity corresponds to higher relative transcript levels compared to the mean 
expression level across all 15 array experiments. Increasing green intensity corresponds to relatively decreased transcript lev-
els compared to the mean. On the right side, examples of individual genes (gene symbols according to S.O.U.R.C.E. [24]) dis-
cussed in the paper or falling into the biological processes and cellular pathways detected by PANTHER are displayed. Detailed 
data on figure 1 is available in additional files 1, 2, 3, 4.
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Cluster analysis of normal male fibroblasts from scrotum and foreskin as well as 46, XY individuals with PAIS and CAIS Figure 2
Cluster analysis of normal male fibroblasts from scrotum and foreskin as well as 46, XY individuals with PAIS 
and CAIS. Hierarchical clustering analysis of 72 microarray experiments of cultured genital fibroblasts using the SAM derived 
gene list. The heatmap on the left displays 259 genes that had at least 85% interpretable data across the experiments whose 
expression levels were at least 2-fold different from the mean expression across all samples in at least 5 microarrays. (A) The 
cluster dendrogram demonstrating the degree of relatedness (Pearson correlation) between the expression patterns of the 
259 genes in the cultured fibroblast samples. The length of the arms of the dendrogram reflects the degree of correlation 
between the samples. Samples are color coded to reflect the localization of the biopsy and the degree of external genital virili-
zation according to a grading scheme developed by Sinnecker et al. [10]. The grey bar below indicates whether a sample was 
derived from dataset 1, 2 or 3. ''L.n.d.'' signifies that the biopsy localization was not accurately documented. Italics indicate a 
sample with a 46, XX karyotype. (B) Schematic depiction of the external genitalia phenotype of the cases from which the 
fibroblast cultures were derived using color coding that corresponds to the degree of genital ambiguity and the location of the 
biopsy. Color coding corresponds to the bar below the dendrogram in (A). (C) Cluster of AR-dependent transcripts that are 
highly expressed in the left ''male'' major branch of the cluster that are expressed at significantly lower levels in the ''female'' 
branch of the cluster on the right. TBX3, previously reported in ulnar mammary syndrome and IGF2, previously reported as 
being down-regulated in CAIS [20] are shown in this cluster. (D) Cluster of AR-dependent transcripts that are expressed at 
significantly lower levels in the lefthand ''male'' branch of the cluster and at higher levels in the righthand ''female'' branch. 
These include many extracellular matrix genes such as proteoglycan testican, versican, and fibrillin 1. Detailed data on figure 2 
is available in additional files 5, 6, 7, 8.
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(labioscrotal swellings)
foreskin
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(genital tubercle)
data set 1 data set 2 data set 3
STX3A,  Syntaxin 3A 
FHL1, Four and a half LIM domains 1
IMPA2, Inositolmyo-1or 4-monophosphatase 2 
MASP1, Mannan-binding lectin serine peptidase 1
CaMKIINalpha, Calcium/calmodulin-dependent protein kinase II inhibitor 1
TBX3, T-box 3 ulnar mammary syndrome
CDC42EP4, CDC42 effector protein Rho GTPase binding 4
C9orf47, Endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 
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Table 1: Fibroblast strains
cell strain micro-array 
data set
anatomic origin 
embryonal anlagen
external 
genitalia AIS-stage
age at biopsy 
years; months
selected functional data (androgen 
binding, AR-genotype, specific 
remarks)
F-33 1 foreskin genital tubercle normal fertile male 51;11 Kd 0.08 nM, Bmax 26 fmol/mg protein
F-40 1, 2 foreskin genital tubercle normal male 7;11 Kd 0.09 nM, Bmax 32 fmol/mg protein
F-52 1 foreskin genital tubercle normal male 0;3 Kd 0.06 nM, Bmax 35 fmol/mg protein
F-56 1, 2 foreskin genital tubercle normal fertile male 42;10 Kd 0.07 nM, Bmax 13 fmol/mg protein
F-57 1 foreskin genital tubercle normal male 5;11 Kd 0.05 nM, Bmax 24 fmol/mg protein
F-58 1 foreskin genital tubercle normal male 5;11 Kd 0.10 nM, Bmax 31 fmol/mg protein
F-59 1, 2 foreskin genital tubercle normal male 0;8 Kd 0.07 nM, Bmax 40 fmol/mg protein
F-60 1 foreskin genital tubercle normal male 5;4 Kd 0.05 nM, Bmax 20 fmol/mg protein
F-62 1 foreskin genital tubercle normal male 2;0 Kd 0.08 nM, Bmax 86 fmol/mg protein
ARD339 1 foreskin genital tubercle ambiguous (AIS3) 1;4 Glu798Gln
ARD082 1 foreskin genital tubercle ambiguous (AIS3) 10;11 Asp604Tyr
ARD183 1 foreskin genital tubercle ambiguous (AIS3) 5;1 Asp756Ser
ARD515 2 foreskin genital tubercle ambiguous (AIS3) 0;6 homozygous missense mutation Arg227Gln 
in SRD5A2 gene leading to 5α reductase 
type II deficiency
S-1 2 scrotum labioscrotal swellings normal male 30;0 no functional data
S-4 2 scrotum labioscrotal swellings normal male 1;3 Kd 0.12 nM, Bmax 44 fmol/mg protein
S-5 2 scrotum labioscrotal swellings normal male 1;7 Kd 0.09 nM, Bmax 28 fmol/mg protein
S-8 2 scrotum labioscrotal swellings normal male 31;0 no functional data
S-9 2 scrotum labioscrotal swellings normal male 34;0 Kd 0.08 nM, Bmax 55 fmol/mg protein
S-11 2 scrotum labioscrotal swellings normal male 32;2 Kd 0.08 nM, Bmax 26 fmol/mg protein
S-12 2 scrotum labioscrotal swellings normal male 9;2 Kd 0.07 nM, Bmax 37.09 fmol/mg protein
ARD527 1, 2, 3 scrotum labioscrotal swellings predominantly male 
(AIS2)
1;6 Leu712Phe, Kd 0.21 nM; Bmax 38 fmol/mg 
protein
ARD446 1 scrotum labioscrotal swellings predominantly male 
(AIS2)
7;8 silent mutation GGG>GGA in codon 795 
of the AR-gene Kd 0.07 nM, Bmax 26 fmol/mg 
protein
ARD407 1, 2 scrotum labioscrotal swellings predominantly male 
(AIS2)
1:0 polyglycin repeat of the N-terminus 
reduced to 10 repeats plus Ala645Asp, Kd 
0.09 nM; Bmax 36 fmol/mg protein
ARD306 1, 2 scrotum labioscrotal swellings predominantly male 
(AIS2)
7;8 Arg855His; Kd 0.97 nM, Bmax 20 fmol/mg 
protein
ARD774 1 scrotum labioscrotal swellings predominantly male 
(AIS2)
0;11 Ala596Thr; Kd 0.08 nM; Bmax 43 fmol/mg 
protein
ARD208 1 labia majora/scrotum 
labioscrotal swellings
ambiguous (AIS3) 1;1 Val746Met; Kd 0.16 nM; Bmax 3 fmol/mg 
protein
ARD534 1 labia majora/scrotum 
labioscrotal swellings
ambiguous (AIS3) 2;4 Arg608Lys
ARD084 1 labia majora/scrotum 
labioscrotal swellings
ambiguous (AIS3) 0;8 no mutation in the whole coding region of 
the AR gene, reduced AR-mRNA, reduced 
AR-protein and reduced ligand binding (Kd 
0.05 nM; Bmax 6 fmol/mg protein)
ARD001 1 labia majora/scrotum 
labioscrotal swellings
ambiguous (AIS3) 0;9 exonic splice site mutation AGC>AGT in 
codon 888 leading to aberrant splicing
ARD380 1 labia majora/scrotum 
labioscrotal swellings
ambiguous (AIS3) 13;1 Arg615Pro, post zygotic mutation leading 
to somatic mosaicism
ARD377 1 labia majora/scrotum 
labioscrotal swellings
predominantly 
female (AIS4)
1;2 Ile841Ser, (Kd 0.55 nM; Bmax 17 fmol/mg 
protein),
ARD659 1 labia majora labioscrotal 
swellings
Predominantly 
female (AIS4) 
3;10 Ala870Gly
ARD1097 1, 2 labia majora labioscrotal 
swellings
normal female 
(CAIS)
1;3 Pro390Ser + Arg855Gly, negative androgen 
binding
ARD411 1, 2 labia majora labioscrotal 
swellings
normal female 
(CAIS)
0;4 Arg855Cys, negative androgen binding
ARD1144 3 labia majora labioscrotal 
swellings
normal female 
(CAIS)
4;3 pathological androgen binding, Kd 1.59 nM, 
Bmax 14 fmol/mg protein, no mutation 
detected
GS641-7/
ARD291
3 labia majora labioscrotal 
swellings
normal female 
(CAIS)
18;4 Phe794Ser, negative androgen bindingBMC Genomics 2007, 8:376 http://www.biomedcentral.com/1471-2164/8/376
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ARD682 1, 2 labia majora labioscrotal 
swellings
normal female 
(CAIS)
14;10 Gln59stop, negative androgen binding, no 
AR-protein in Western immunoblot
ARD402 1, 2 labia majora labioscrotal 
swellings
normal female 
(CAIS)
1;0 2 base pair deletion in exon 1, frameshift, 
premature stop codon, negative androgen 
binding, very low AR-mRNA transcription, 
no AR-protein in Western immunoblot
ARD075 1, 2 labia majora labioscrotal 
swellings
normal female 
(CAIS)
12;3 Arg774Cys, post zygotic mutation leading 
to somatic mosaicism, Kd1 0.03 nM; Bmax1 2 
fmol/mg protein (wilde type AR); Kd2 8.5 
nM; Bmax2 29 fmol/mg protein (mutant AR)
ARD465 1 labia majora labioscrotal 
swellings
normal female 
(CAIS)
5;5 Glu287stop, low expression of wild-type 
AR (Kd 0.11 nM; Bmax 4 fmol/mg protein), 
post-zygotic mutation (somatic mosaicism 
likely)
L-1 3 labia minoraurethral folds normal female 37;10 normal female (46, XX)
L-2 3 labia minoraurethral folds normal female 23;0 female (46 XX), classical congenital adrenal 
hyperplasia due to 21-hydroxylase 
deficiency, external genital virilization of 
Prader 3 corresponding phenotypically to 
"AIS3"
L-3 3 labia majora labioscrotal 
swellings
normal female 40;4 normal female (46, XX)
ARD709 1t e s t i s   gonad ambiguous (AIS3) 6;5 Met775Ile
ARD291 1t e s t i s   gonad normal female 
(CAIS)
18;4 Phe794Ser, negative androgen binding
ARD531 1t e s t i s   gonad normal female 
(CAIS)
35,2 Ala765Thr, negative androgen binding
ARD557 1t e s t i s   gonad normal female 
(CAIS)
6;6 donor splice site exon 2/intron 2, negative 
androgen binding
ARD842 1t e s t i s   gonad normal female 
(CAIS)
38;0 26 bp deletion exon 1 (141–150), 
frameshift, premature stop codon, negative 
androgen binding
ARD1004 1t e s t i s   gonad normal female 
(CAIS)
17;4 Val866Met, negative androgen binding
N-ST4 1 abdominal skin normal male 46;0 no functional data
N-LS12 1 forearm skin normal male 36;0 no functional data
Fibroblast strains; microarray dataset in whichh they have been analysed (1 – 3); ARD or GS, patient strain-ID; F, normal male foreskin fibroblasts; 
S, normal male scrotal fibroblasts. L-1-3 represent the only samples with a 46, XX karyotype. N-ST4 and N-LS12 are of extragenital origin. ARD515 
was derived from a 46, XY male with ambiguous genitalia due to a 5α reductase type II defect rather than AIS. Normal ranges for androgen 
(methyltrienolone) binding: Bmax (binding capacity): 13–116 fmol/mg protein; Kd (dissociation constant): 0.03–0.13 nM.
Table 1: Fibroblast strains (Continued)
system suggested by Sinnecker [10] wherein phenotypi-
cally male genitalia are scored AIS 1, while female external
genitalia are scored AIS 5 (Fig. 2B). Stringent filtering con-
ditions of the combined data sets reduced the number of
transcripts from 612 to 259; however, altering the strin-
gency of the filtering conditions and the number of tran-
scripts used did not significantly change the clustering
pattern of the individual samples (data not shown).
Clustering separated the 72 experiments into two major
subgroups. The righthand major branch included pre-
dominantly patients with female external genitalia while
most of the patients in the lefthand major branch had
normal male or highly virilized external genitalia (Fig. 2A
and 2B). All but one of the samples with CAIS (AIS 5) and
a normal 46, XX female clustered in the right ("female")
branch (Fig. 2A). Interestingly, the one exception
expressed a wild type AR in a portion of cells due to
somatic mosaicism (ARD465). Two skin fibroblast sam-
ples from normal males derived from regions without an
obvious androgen induced sexual dimorphism (abdo-
men, forearm) also clustered in the right ("female")
branch. The left ("male") major branch contained all gen-
ital skin fibroblasts derived from normal male controls
and 8 of 10 microarry experiments reflecting patients with
higher degrees of virilization due to partial AIS (AIS 2).
This cluster also included a fibroblast sample from an
individual with 5α-reductase type II deficiency, a defect
which results in ambiguous genitalia due to lack of con-
version of testosterone to dihydrotestosterone. This indi-
vidual presumably possesses a wild-type AR, meaning that
androgen signaling pathways remained intact. Three of
the four labioscrotal fibroblast samples from individuals
with AIS 3 phenotypes with significant genital ambiguity
clustered in the "female" major branch and the remaining
in the "male" one (Fig. 2). Of note, clustering did notBMC Genomics 2007, 8:376 http://www.biomedcentral.com/1471-2164/8/376
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appear to be influenced by array type or RNA reference-
type, indicating that normalization procedures did not
influence data quality.
Structure within the cluster dendrogram suggested that
there was some residual influence of topology on gene
expression in the samples. In the righthand "female"
branch, fibroblast samples derived from AIS gonads clus-
tered separately from all skin-derived samples (Fig. 2A).
Similarly, the lefthand "male" branch showed a subcluster
that contained all the foreskin-derived fibroblasts, includ-
ing the AIS 2 fibroblasts originating from the foreskin.
Interestingly, this branch also contained two strains of
labia minora fibroblasts from two 46, XX individuals, one
of whom had ambiguous genitalia (Prader stage 3) due to
21-hydroxylase deficiency (female pseudohermaphro-
ditism), while the other individual was a normal female.
Since the labia minora are analogous to the urethral folds
that participate in penile morphogenesis, this finding sug-
gests that topographic origin influenced expression within
the selected set of genes of these two samples more than
AR signaling. In some cases, the anatomic origin of biopsy
was not well documented (table 1). This might explain
why some samples did not cluster as expected (e.g.,
ARD380 and ARD659, Fig. 2A) although other factors
might have contributed to these findings.
We also wanted to reconsider whether the new topology-
independent, AR gene list better classified samples than
our previous gene list that did not control for the loca-
tions from which samples were harvested. After removing
the microarray experiments that were used to define either
the previous [8] or the new gene set by SAM, the remain-
ing samples were clustered. As expected, in case of both
gene lists the samples sorted into two main branches that
separated primarily male and female samples (Fig. 3A and
3B). Moreover, when we considered only topology-con-
trolled samples originating from the labioscrotal swell-
ings excluding the mosaic samples and those of
insufficiently described biopsy localization, the mean AIS-
grades between the two branches differed significantly
using both gene lists (new gene list: AIS-grades: 2.5 ± 0.55
(male); 4.17 ± 1.12 (female); p < 0.001 by t-test; previous
gene list (Holterhus et al. 2003): AIS-grades: 1.6 + 0.79
(male); 3.3 + 1.6 (female); p < 0.01 by t-test). However, in
contrast to the new gene set, the previous gene set that did
not account for topology misclassified many individuals.
It resulted in incorrectly female classification of most of
the highly virilized individuals with AIS 2 (3 of 4 individ-
uals = 75%) and of a large fraction of the normal male
scrotal fibroblast controls (3 of 7 individuals = 43%) (Fig.
3A and 3B). The new gene set misclassified only one indi-
vidual with AIS 2 (ARD306).
Biological processes in the AR-dependent gene expression 
program
We performed a systematic analysis for enrichment of
genes belonging to defined biological processes and cellu-
lar pathways using the PANTHER classification system
[11]. PANTHER classifies genes by their functions, based
on published experimental evidence and on evolutionary
relationships. The 612 significant transcripts corre-
sponded to 527 named transcripts, of which PANTHER
recognized 440 unique gene IDs. Several related biologi-
cal processes were significantly over-represented in the
AR-dependent gene list including "control of cell prolifer-
ation and differentiation" (p = 0.00001, "developmental
processes" (p = 0.00013) and "cell cycle control" (p =
0.00041) (table 2). Analysis of cellular pathways also
revealed several interesting signaling pathways including
"angiogenesis" (p = 0.00001) and WNT-signaling" (p =
0.00002) (table 3). These processes and pathways were
reflected in the major branches of the cluster dendrogram
revealing differential expression in the phenotypically
male and female samples (Figures 2C and 2D). For
instance, samples in the "male" branch showed high
expression of CCN1 (cyclin 1), CCND1 (cyclin D1), IGF2
(insulin-like growth factor 2), IGFBP5 (Insulin-like
growth factor binding protein 5), MYC (V-myc myelocy-
tomatosis viral oncogene homolog), MAFF (V-maff musc-
uloaponeurotic fibrosarcoma oncogene homolog F),
EGFR (epidermal growth factor receptor), PTPN3 (protein
tyrosine phophatase), MET (hepatocyte growth factor
receptor) and several other genes important in cell growth
and proliferation (Fig. 1 and 2A). Transcripts expressed at
high levels in the "female" branch included ANAPC7
(anaphase promoting complex subunit 7), FZD8 (frizzled
homolog 8) and FZD6 (frizzled homolog 6) (Fig. 1).
The AR-dependent gene set showed enrichment for a
number of genes related to maintenance and modifica-
tion of tissue shape and structural identity (Tables 2 and
3, and Fig. 2D). Genes that were up-regulated in the pre-
dominately male branch were SDC1 (syndecan 1), FMOD
(fibromodulin) and ADAMTS2 (A disintegrin-like and
metalloproteinase with thrombospondin type 1 motif, 2).
Those up-regulated mainly in the female branch included
ADAM12 (A disintegrin and metalloproteinase 12), TNC
(tenascin C), CSPG2 (chondroitin sulfate proteoglycan 2,
versican), FBN1 (fibrillin 1), ELN (elastin), COL5A2 (col-
lagen, type V, alpha2), ECM2 (extracellular matrix protein
2, female organ and adipocyte specific), DAG1 (dystrogly-
can 1), and SPOCK (sparc/osteonectin, cwcv kazal-like
domains proteoglycan, testican).
Confirmation of selected transcripts by RT-PCR
Four transcripts were selected for confirmation of the
microarray data by semi-quantitative RT-PCR: TNC
(tenascin), FZD8 (frizzled 8), ADAM12 (ADAM metal-BMC Genomics 2007, 8:376 http://www.biomedcentral.com/1471-2164/8/376
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lopeptidase 12), and CSPG2 (chondroitin sulfate prote-
oglycane 2, versican). RNA from the labia majora
fibroblasts derived from CAIS affected individuals
(ARD402, ARD411, ARD682, ARD1097), as well as four
samples of the normal male scrotal fibroblasts (S4, S5, S8,
S9) were used for analysis. In agreement with the microar-
ray data, TNC, FZD8, ADAM12 and CSPG2 show signifi-
cantly higher expression in the labia majora fibroblasts
compared to the scrotal fibroblasts (Fig. 4).
Discussion
We demonstrate reproducible, lasting differences in gene
expression in cultured fibroblasts harvested from analo-
gous structures in the genital tissues of normal males and
46, XY CAIS females. This unique model system, in which
samples were matched for genotype and topology, allows
identification of gene expression programs predomi-
nantly influenced by AR signaling, likely during genital
morphogenesis. By selecting fibroblasts derived from the
labioscrotal swellings in normal and CAIS individuals, we
were able to largely exclude androgen-independent mech-
anisms as a cause of systematic differences of baseline
gene expression. While we had identified a related set of
genes previously using fibroblast cells that had not been
matched for site of origin, the significant differences
between our previous and current gene sets implies that
topology significantly influenced gene expression in our
original set. This finding is instructive for future studies
Experiment clustering with topography controlled (A) – versus previous (B) [8] gene set Figure 3
Experiment clustering with topography controlled (A) – versus previous (B) [8] gene set. Hierarchical clustering 
analyses of microarray experiments using the new topology-independent AR gene list (A) and our previous gene list [8] that 
did not control for topology of biopsy location (B). In each of the two clusters A and B, the microarray experiments used to 
generate the underlying list of significant genes by SAM were removed before clustering resulting 57 remaining experiments in 
(A) and 58 in (B), respectively. The color code is the same as in Fig. 2. Based on the previous gene set, several highly virilized 
AIS 2 patients and normal scrotal fibroblasts were incorrectly classified female.
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seeking to identify the effects of inactivating mutations of
single genes in tissues or cells cultured from tissues. Gene
expression profiles can be influenced by obvious geno-
typic differences, such as the presence of an X or Y chro-
mosome [6] but also by subtle differences including
differences in topology [9].
The transcripts we have identified appear to be highly rel-
evant to male and female external genital morphogenesis.
When used to classify an independent set of fibroblasts
cultured from normal male, normal female, and PAIS-
affected individuals, this gene set performed considerably
better than our previous set in which we had not control-
led for differences in topology. The observation that
fibroblasts derived from the labia majora of normal
female external genitalia clustered with AIS derived sam-
ples from the same site demonstrates the primacy of
developmental androgen actions in influencing gene
expression in this set of genes, and possibly in external
genital morphogenesis. Furthermore, our findings suggest
that gene expression profiling of genital fibroblasts might
be correlated with phenotype in vivo and could serve as a
diagnostic marker of the extent of developmental andro-
genization, although many more cases will need to be
analyzed, and other analytic methods will need to be used
to identify an ideal classifier.
Chang and co-workers have demonstrated that fibroblasts
cultured from different regions of the body retain posi-
tion-specific expression signatures [9]. Our work confirms
the presence of lasting, topology-influenced differences in
gene expression in human fibroblasts. Controlling for the
site from which genital fibroblasts were derived signifi-
cantly altered the set of genes we identified as differing
between normal and CAIS-derived fibroblasts. Despite
that control, signatures of topology remained in our new
Table 2: Biological processes
Biological process Detected number 
of genes in SAM list
Expected number of genes 
based on NCBI reference list
P-value
Cell proliferation and differentiation 40 18.46 0.00001
Intracellular signaling cascade 35 15.59 0.00001
Protein phosphorylation 28 12.07 0.00005
Protein modification 40 20.81 0.00008
Developmental processes 61 37.57 0.00013
Biological process unclassified 157 193.59 0.00024
Cell cycle control 18 7.16 0.00041
Cell structure and motility 36 20.29 0.00076
Signal transduction 86 61.52 0.0008
Extracellular matrix protein-mediated signaling 6 1.09 0.00091
AR-dependent biological processes identified by PANTHER (Thomas et al. 2003) [11] as significantly over-represented in the SAM-list compared to 
the NCBI human reference gene list (table limited to genes with p < 0.001)
Table 3: Cellular pathways
Cellular pathway Detected number of 
genes in SAM-list
Expected number of genes 
based on NCBI reference list
P-value
Angiogenesis 16 4.12 0.00001
Wnt signaling 20 6.71 0.00002
T cell activation 10 2.26 0.00012
Inflammation mediated by chemokine and cytokine signaling 
pathway
16 5.9 0.00038
Endothelin signaling pathway 8 1.84 0.00145
Muscarinic acetylcholine receptor 1 and 3 signaling pathway 5 0.81 0.00145
Integrin signaling pathway 12 4.44 0.00202
Alpha adrenergic receptor signaling pathway 4 0.53 0.00209
EGF receptor signaling pathway 8 2.56 0.00470
Unclassified 370 388.65 0.00476
Axon guidance mediated by semaphorins 5 1.15 0.00636
PDGF signaling pathway 9 3.38 0.00781
Ras pathway 6 1.73 0.00852
AR-dependent cellular pathways identified by PANTHER (Thomas et al. 2003) [11] as significantly over-represented in the SAM-list compared to the 
NCBI human reference gene list (table limited to genes with p < 0.01)BMC Genomics 2007, 8:376 http://www.biomedcentral.com/1471-2164/8/376
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Verification of selected genes by RT-PCR Figure 4
Verification of selected genes by RT-PCR. The ratio of transcript levels of TNC (Tenascin), FZD8 (Frizzled 8), ADAM12 
(ADAM metallopeptidase 12), and CSPG2 (Chondroitin sulfate proteoglycane 2, versican) comparing CAIS cell lines and nor-
mal scrotal cell lines. Semi-quantitative RT-PCR was performed on four samples of normal male scrotal fibroblasts (S4, S5, S8, 
S9), as well as on four samples of labia majora derived from CAIS patients (ARD402, ARD411, ARD682, ARD1097). Differ-
ences in expression levels between different cell lines were calculated according to the ΔΔ-CT method [19]. The y-axis repre-
sents the ratios of expression levels of CAIS labia majora fibroblasts divided by those from scrotal fibroblasts.
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gene set. For instance, normal male fibroblasts and CAIS-
derived gonadal fibroblasts each clustered as distinct enti-
ties in the "male" and "female" arms, respectively. Thus,
even in our stringently selected fibroblast samples and
gene set, topology remains evident in the gene expression
profile. Although Chang and co-workers have found that
HOX gene signatures account for much of the topological
gene classifier, our gene list lacked HOX genes, implying
that traces of topology remain encoded in other sets of
transcripts. Together with the results of Chang et al., our
work demonstrates substantial heterogeneity in gene
expression in cultured fibroblasts that can be influenced
by topology and, in the case of our unique fibroblast sam-
ples, AR signaling. We suspect that other signaling path-
ways, possibly including other steroid hormones or
growth factors, can program lasting changes gene expres-
sion in fibroblasts. Whether these differences in gene
expression can influence development of associated tis-
sues in vivo remains to be elucidated. Regardless, our data
suggests one possible model system for teasing out the
effects of mutations in single genes on global gene expres-
sion patterns in cells cultured from in vivo models.
The biological processes and the cellular pathways
enriched in the AR-dependent gene set could provide
some insights into the role of AR-mediated programming
of fibroblasts in male and female external genital differen-
tiation. For instance, activation of several growth signal-
ing pathways in male derived fibroblasts and WNT
signaling pathways in female genital fibroblasts, e.g.,
FZD8 (Fig. 1, 2 and 4), might signal their important roles
in genital development. The same could be true for genes
contributing to maintenance and modification of tissue
shape and structural identity, e.g., versican, tenascin, and
ADAM12 (Fig. 1, 2 and 4). It is unclear, however, whether
expression of these genes in cultured fibroblasts reflects
their expression in vivo, whether expression is necessary
for maintenance of external genital structure, or whether
these pathways are reactivated as a result of cell culture.
Moreover, it cannot be excluded that potentially higher
cumulative estrogens during development and postnatal
life in the AIS patients until the time of genital skin biopsy
may have had additional influences on gene expression. It
is possible that the gene expression programs have little to
do with genital development; however, the finding that
many genes related to cell and tissue structure and integ-
rity is tantalizing. We identified many genes of the
cytoskeletal network (KRT5, 19, 25A, MYO10) and of the
surrounding extracellular matrix (TNC, SPOCK, CSPG2,
COL5A2) in the AR-dependent gene expression data set
[12-14]. Additional in vivo work including strategies com-
prising early embryonal urogenital tissues will clarify
whether genes identified using our approach are impor-
tant in external genital morphogenesis.
Conclusion
Our data demonstrate the existence of large-scale AR-
dependent gene expression programs in fibroblasts cul-
tured from human external genitalia. These programs are
influenced neither by differences in sex chromosomes nor
by the topographic differences between the genital tuber-
cle and the labioscrotal swellings. Improved classification
of individuals with partial and complete androgen insen-
sitivity syndrome with this gene list compared to a set we
had identified previously suggests that androgen pro-
gramming must have played a key role in establishing
these programs. Therefore, the detected genes represent
valuable targets for unraveling human external genital dif-
ferentiation and the role of androgen therein.
Methods
The study was approved by the ethical committee of the
University of Lübeck, Germany. Informed consent was
obtained from the control subjects, affected individuals or
their parents.
Cell strains
A total of 51 different primary fibroblast cultures were
analyzed (table 1). Genital fibroblasts were established
from scrotal skin biopsies from normal males undergoing
orchidopexy or testis biopsy (scrotal fibroblasts) or from
circumcisions (foreskin fibroblasts). Normal female geni-
tal skin fibroblasts were established from individuals
undergoing genital plastic surgery (labia majora fibrob-
lasts). Genital skin fibroblasts of patients with disorders of
sex development (DSD, [15]), mostly AIS, were obtained
either for diagnostic reasons or during reconstructive sur-
gery (foreskin-derived or labioscrotal-derived or labial
fibroblasts) or following gonadectomy (gonadal fibrob-
lasts). Extra-genital skin fibroblasts were obtained from
phenotypically normal male individuals. For gene expres-
sion profiling, fibroblasts of the 3rd to 7th passage were
cultured to confluency (wherein they entered G0 arrest), as
described previously [8].
RNA-isolation and cDNA-labeling
Protocols for mRNA and total RNA preparation, and
cDNA labeling are available at  [16]. Either 2 μg of mRNA
(dataset 1) or 50 μg of total RNA (datasets 2 and 3) from
genital fibroblasts were reverse transcribed and labeled
with Cy5. Labeled cDNAs from genital fibroblasts were
mixed with Cy-3-labeled reference RNA from Stategene
(datasets 2 and 3) or a pooled reference of RNA from
fibroblasts and 11 immortalized cell lines (dataset 1, see
[8]).
Microarrays and hybridizations
Poly L-lysine coated (data set 1 = 19 new hybridized
micoarrays plus 22 previously published microarrays [8]
and dataset 2 = 24 new hybridized microarrays) or Corn-BMC Genomics 2007, 8:376 http://www.biomedcentral.com/1471-2164/8/376
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ing glass slide (data set 3 = 7 new hybridized microarrays)
spotted cDNA-microarrays containing more than 44,000
elements corresponding to approximately 26,000 unique
genes (UniGene clusters) were used for gene expression
analysis (for details, see [16]). Hybridizations were per-
formed using equal amounts of Cy3 and Cy5 labeled
cDNAs according to previously published protocols for
14–18 hours over night at 65°C. Hybridized microarrays
were scanned using a GenePix4000 array scanner and ana-
lyzed with GenePix Pro software (Axon Instruments, Inc.,
Union City, CA).
Microarray data analysis
To identify genes differentially expressed in homologous
tissues of normal male and CAIS female derived fibrob-
lasts, we restricted our analysis to samples derived from
the labioscrotal swellings (scrotum or labia majora), that
were hybridized on poly-lysine coated slides against
Strategene reference RNA (data set 2). Only spots with flu-
orescence signals of 1.5-fold over array background in
either the experimental or reference channel were consid-
ered. The Cy5/Cy3 fluorescence ratios for all genes in each
array were normalized to obtain an average absolute log2
red/green ratio of 0 and the fluorecence ratios for each
gene were mean centered. The Significance Analysis of
Microarrays (SAM) procedure [17] was used to identify
transcripts with statistically significant differences in
expression levels between normal and CAIS samples.
Identified transcripts were used to perform hierarchical
clustering analysis of 72 microarray experiments per-
formed on fibroblasts derived from normal males, and
individuals affected with PAIS and CAIS. To correct for dif-
ferences in the reference RNA (dataset 1 versus dataset 2
and 3) and slide coating (dataset 1 and 2 versus dataset 3),
normalized log2 red/green ratios for single genes were cen-
tered by the mean in each of the three datasets separately
according to a previously published procedure [18]. Cen-
tered data from the three data sets were combined and
again were mean-centered for each gene. In the combined
dataset, only genes with measurable data in 85% of the 72
experiments were considered. Restriction of the analysis
to genes which had absolute values of normalized log2
red/green ratios ≥ 1.0 in at least 5 experiments of the sam-
ple set of 72 microarrays resulted in 259 transcripts.
Microarray experiments and genes were organized by hier-
archical clustering, using the Pearson correlation metric
and average linkage clustering [19]. TreeView software
was used to visualize the results [19]. Supplementary
information on each of the microarray experiments and
all datasets are available online [22,23]. For figure 1
please see additional files 1, 2, 3, 4, for figure 2, please see
additional files 5, 6, 7, 8.
Functional classification of sexually dimorphic genes
SAM identified transcripts were loaded into the PANTHER
(Protein ANalysis THrough Evolutionary Relationships)
database. Enrichment of biological processes and cellular
pathways in the AR dependent gene list was determined
by comparing the number of genes observed in the SAM-
list for each process or pathway to the number of genes
expected based on the NCBI Homo sapiens reference gene
list. PANTHER determines a p-value based on binominal
statistics, describing the probability that the number of
detected genes occurred randomly, with a p-value < 0.05
indicating significance [11]. Since many pathways can be
identified, we focused our discussion on a subset in bio-
logical processes with p < 0.001 and in cellular pathways
with p < 0.01.
RT-PCR analyses
Semi-quantitative RT-PCR was performed using FAM (F)
labeled probes with dabcyl (DB) quencher. RT-PCR was
performed on four samples of normal male scrotal fibrob-
lasts (S4, S5, S8, S9) as well as on four samples of labia
majora derived from CAIS patients (ARD402, ARD411,
ARD682, ARD1097). Exon-spanning primers and probes
(TIB Molbiol, Berlin, Germany) had the following
sequences: Tenascin: TNC-forward: ACAgTgggACAgCAg-
gTgACT, Tm: 59.6°C; TNC-reverse: CAggTTgACACggT-
gACAgTTC, Tm: 59.4°C, TNC labeled probe: F-
TACCACAATggCAgATCCTTCTCCACCT-DB, Tm: 66.7°C;
Frizzled 8: FZD8-forward: gTgCAgCgAAgggACACTTg, Tm:
61.0°C; FZD8-reverse: TCCTCAgCCAACAgAAATTAACg,
Tm: 58.7°C, FZD8 labeled probe: F-AggTTCCCACCCCT-
TCACAgTgTTgA-DB, Tm: 67.9°C; ADAM metallopepti-
dase 12: ADAM12-forward: CCTggCACCCCTCAgACC,
Tm: 60.9°C, ADAM12-reverse: gTACAAAAAACTC-
CAACTggAgCTg, Tm: 59.4°C, ADAM12 labeled probe: F-
TCCACACCAAgTgCCCAgATCCAC-DB, Tm: 67.0°C;
Chondroitin sulfate proteoglycane 2, versican: CSPG2-
forward: TgTCTCACgAAgAACAAATgTTTgT, Tm: 58.0°C,
CSPG2-reverse: gggTCTCCAATTCTCgTATTgCA, Tm:
59.8°C, CSPG2 labeled probe: F-TgCCATCAgTCCAACg-
gAAgTCATgCT-DB, Tm: 69.3°C; TATA-binding protein
(TBP) was used to normalize expression values. TBP prim-
ers were TBP-forward: CACgAACCACggCACTg-ATT, TBP-
reverse: TTTTCTTgCTgCCAgTCTggAC; TBP-labeled probe:
F-TgTgCAC-AggAgCCAAgAgTgAAgA-DB. Reverse tran-
scription was performed using the Ambion RETROscript
kit according to the manufacturer's recommendations
with minor modifications. 2 μg of total RNA, 0.5 μM
dNTPs, 5 μM random decamers and 200 units of MMLV-
RT polymerase were used per reaction. Heat denaturation
was performed for 3 min at 85°C preceding reverse tran-
scription for 1 hr at 44°C and subsequent inactivation for
10 min at 92°C. C-DNA corresponding to 12 ng of initial
total RNA served as template for amplification reactions.
0.4 μM of each primer, 0.17 μM of specific probe and Taq-BMC Genomics 2007, 8:376 http://www.biomedcentral.com/1471-2164/8/376
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Man Universal PCR mastermix (Applied Biosystems, Fos-
ter City, CA, USA) including the Taq polymerase were
added to a final volume of 25 μl. Initial denaturation was
performed at 95°C for 10 min followed by 1 min cycling
intervals at 60°C using a RotorGene RG-3000 cycler (Cor-
bett-Research, Sydney, Australia). Differential transcrip-
tion levels between all different cell lines were calculated
according to the ΔΔ-CT method [20].
Abbreviations
AR, androgen receptor; AIS, androgen insensitivity syn-
drome; CAIS, complete androgen insensitivity syndrome;
PAIS, partial androgen insensitivity syndrome
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